Cargando…

Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis

Detalles Bibliográficos
Autores principales: Papadopoulou, Charalampia, Hong, Ying, Omoyinmi, Ebun, Brogan, Paul A, Eleftheriou, Despina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391598/
https://www.ncbi.nlm.nih.gov/pubmed/30715143
http://dx.doi.org/10.1093/brain/awz005
_version_ 1783398340597121024
author Papadopoulou, Charalampia
Hong, Ying
Omoyinmi, Ebun
Brogan, Paul A
Eleftheriou, Despina
author_facet Papadopoulou, Charalampia
Hong, Ying
Omoyinmi, Ebun
Brogan, Paul A
Eleftheriou, Despina
author_sort Papadopoulou, Charalampia
collection PubMed
description
format Online
Article
Text
id pubmed-6391598
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-63915982019-07-26 Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis Papadopoulou, Charalampia Hong, Ying Omoyinmi, Ebun Brogan, Paul A Eleftheriou, Despina Brain Letters to the Editor Oxford University Press 2019-03 2019-02-01 /pmc/articles/PMC6391598/ /pubmed/30715143 http://dx.doi.org/10.1093/brain/awz005 Text en © The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Papadopoulou, Charalampia
Hong, Ying
Omoyinmi, Ebun
Brogan, Paul A
Eleftheriou, Despina
Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
title Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
title_full Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
title_fullStr Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
title_full_unstemmed Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
title_short Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
title_sort janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391598/
https://www.ncbi.nlm.nih.gov/pubmed/30715143
http://dx.doi.org/10.1093/brain/awz005
work_keys_str_mv AT papadopouloucharalampia januskinase12inhibitionwithbaricitinibinthetreatmentofjuveniledermatomyositis
AT hongying januskinase12inhibitionwithbaricitinibinthetreatmentofjuveniledermatomyositis
AT omoyinmiebun januskinase12inhibitionwithbaricitinibinthetreatmentofjuveniledermatomyositis
AT broganpaula januskinase12inhibitionwithbaricitinibinthetreatmentofjuveniledermatomyositis
AT eleftherioudespina januskinase12inhibitionwithbaricitinibinthetreatmentofjuveniledermatomyositis